Cargando…

RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants

OBJECTIVES: To compare the RNA loads of severe acute respiratory syndrome coronavirus 2 in nasopharyngeal specimens collected from patients with breakthrough coronavirus disease 2019 (COVID-19) caused by the Delta variant with those in specimens collected from patients with breakthrough COVID-19 cau...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Michelena, Paula, Torres, Ignacio, Ferrando, Enric-Cuevas, Olea, Beatriz, González-Candelas, Fernando, Sánchez, Gloria, Navarro, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474403/ https://www.ncbi.nlm.nih.gov/pubmed/36115649 http://dx.doi.org/10.1016/j.cmi.2022.09.003

Ejemplares similares

SARS‐CoV‐2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID‐19 due to Omicron BA.1 and BA.2
por: de Michelena, Paula, et al.
Publicado: (2022)

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19
por: de Michelena, Paula, et al.
Publicado: (2022)

RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status
por: Costa, Rosa, et al.
Publicado: (2022)

Secondary Cases of Delta Variant Coronavirus Disease 2019 Among Vaccinated Healthcare Workers With Breakthrough Infections is Rare
por: Waldman, Sarah E, et al.
Publicado: (2021)

GenomeBits insight into omicron and delta variants of coronavirus pathogen
por: Canessa, Enrique, et al.
Publicado: (2022)

Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment
por: Ngonghala, Calistus N., et al.
Publicado: (2023)

Recovering coronavirus from large volumes of water
por: Cuevas-Ferrando, Enric, et al.
Publicado: (2021)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks
por: Akaishi, Tetsuya, et al.
Publicado: (2022)

Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
por: Adachi, Eisuke, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida
por: Rife Magalis, Brittany, et al.
Publicado: (2022)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
por: Martínez-González, Brenda, et al.
Publicado: (2022)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Croup during the Coronavirus Disease 2019 Omicron Variant Surge
por: Tunҫ, Emine M., et al.
Publicado: (2022)

Incubation period of the coronavirus disease 2019 (COVID-19) in Busan, South Korea
por: Lee, Hansol, et al.
Publicado: (2020)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity
por: Rocco, Joseph M, et al.
Publicado: (2021)

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
por: Shapiro, Leland, et al.
Publicado: (2023)

Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
por: Christensen, Paul A., et al.
Publicado: (2022)

Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants
por: Kislaya, Irina, et al.
Publicado: (2022)

Clinical manifestations and outcomes of coronavirus disease 2019 among pediatric liver transplant recipients in the delta and omicron variant pandemic: A retrospective study
por: Getsuwan, Songpon, et al.
Publicado: (2023)

Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England
por: Gates, Shannah, et al.
Publicado: (2023)

Identification of severe acute respiratory syndrome coronavirus 2 breakthrough infections by anti-nucleocapsid antibody among fully vaccinated non-healthcare workers during the transition from the delta to omicron wave
por: Dai, Yu-Ching, et al.
Publicado: (2022)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves
por: Chandrasingh, Sindhulina, et al.
Publicado: (2023)

Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019
por: Rafiullah, Mohamed, et al.
Publicado: (2020)

Coronavirus diseases 2019 (COVID-19) response: Highlights of Ghana's scientific and technological innovativeness and breakthroughs
por: Sibiri, H., et al.
Publicado: (2020)

Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022)

An interactive tool to forecast US hospital needs in the coronavirus 2019 pandemic
por: Locey, Kenneth J, et al.
Publicado: (2020)

Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?()
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: A case-series study
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan
por: Yao, Kenta, et al.
Publicado: (2021)

The International Response to the Coronavirus Disease (2019) COVID-19 Pandemic in Radiation Oncology
por: Wang, Edina, et al.
Publicado: (2020)

Time to resolution of respiratory and systemic coronavirus disease 2019 symptoms in community setting
por: Dinh, Aurélien, et al.
Publicado: (2021)

Emotions and mood swings of pharmacy students in the context of the coronavirus disease of 2019 pandemic
por: Campos, Juliana Alvares Duarte Bonini, et al.
Publicado: (2021)

Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
por: Hu, Fei-Hong, et al.
Publicado: (2023)

Decreased Risk of Coronavirus Disease 2019–Related Hospitalization Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2
por: Ridgway, Jessica P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jnbh7pu5hk2dcf67k5561i3p82